Quince Therapeutics Inc.

NASDAQ: QNCX · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT

Quince Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-42.42M -60.71M -56.83M -53.26M -53.12M -30.28M -31.39M -28.02M -30.59M -42.27M -51.66M -69.53M -83.31M -88.5M -89.94M -87.1M -86.9M -82.76M
Depreciation & Amortization
163K 178K 186K 474K 388K 345K 322K 60K 100K 183K 204K 246K 293K 296K 344K 345K 342K 335K
Stock-Based Compensation
-2.95M 4.86M 4.75M 4.71M 4.91M 5.01M 5.22M 5.77M 5.13M 8.86M 16.62M 23.48M 30.4M 32.1M 29.85M 26.32M 22.86M 19.51M
Other Working Capital
5.93M 1.48M -1.41M -1.58M -2.38M 877K 2.27M 735K 1.25M -679K -3.89M -4.56M -4.22M -11.12M -5.62M -1.1M 3.56M 10.23M
Other Non-Cash Items
5.83M 17.77M 18.1M 19.22M 23.71M 3.24M 6.79M 3.58M 5.36M 6.89M 1.2M 68.15M 67.11M 66.99M 66.94M 291K 371K 367K
Deferred Income Tax
n/a n/a n/a -1.82M -1.82M -965K -1.21M 608K 324K -816K -568K -67.11M -66.59M -66.07M -65.87M 885K 849K 781K
Change in Working Capital
10.04M 4.75M 1.9M 250K -2.06M -433K 1.98M -40K -242K -4.36M -9.83M -7.86M -11.17M -10.23M -4.26M -2.53M 5.66M 8.12M
Operating Cash Flow
-29.34M -33.15M -31.9M -30.43M -27.99M -23.08M -18.29M -18.05M -19.93M -31.52M -44.04M -52.62M -63.27M -65.41M -62.93M -61.79M -56.82M -53.65M
Capital Expenditures
-596K -366K -257K -148K -102K -63K -160K -214K -264K -10.89M -10.76M -10.73M -10.68M -148K -180K -146K -166K -84K
Cash Acquisitions
-135K n/a n/a -2.12M -2.12M -2.12M -2.03M 10.52M 10.56M 21.18M 21.23M 11.68M 11.64M 1.01M 1.08M 837K 837K 837K
Purchase of Investments
-10.63M -52.22M -89.56M -108.23M -149.37M -145.38M -113.78M -103.37M -88.3M -73.75M -75.02M -69.78M -50.47M -35.77M -38.79M -39.56M -72.9M -103.58M
Sales Maturities Of Investments
40.32M 73.78M 109.38M 125.56M 165.55M 146.18M 111.21M 111.51M 83.5M 73.39M 82.49M 79.47M 69.74M 76.64M 97.92M 93.57M 136.53M 155.56M
Other Investing Acitivies
3.43M 2.7M 2.35M 1.36M -1M -1.02M -1.01M -10.95M -10.41M 236.68K 96K 9.65M 10.38M 5.48M 5.41M 5.65M 15.28M 3.62M
Investing Cash Flow
32.39M 23.89M 21.91M 16.43M 12.96M -2.38M -5.76M 7.52M -4.94M 10.13M 18M 20.25M 29.85M 40.72M 58.95M 53.86M 63.46M 51.89M
Debt Repayment
n/a n/a n/a -6K -6K -6K -12K -24K -43K -43K -37K -19K n/a n/a n/a -2K -2K -5K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a 16.5M 16.5M 16.5M 16.5M n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
8.88M -5M -5M -4.99M 6K 32K 88K 82K 96K 178K 136K 1.13M 5.82M 6.38M 6.81M 5.87M 1.25M 1.47M
Financial Cash Flow
8.96M -4.88M -4.78M -4.72M 292K 283K 143K 68K 53K 135K 707K 1.72M 6.42M 6.99M 6.81M 5.86M 1.25M 1.47M
Net Cash Flow
-50.86M -14.04M -14.54M -18.96M -14.76M -24.9M -23.83M -10.18M -24.28M -20.85M -25.14M -30.4M -27.12M -17.75M 2.88M -2.04M 7.89M -291K
Free Cash Flow
-29.93M -33.52M -32.16M -30.58M -28.09M -23.14M -18.45M -18.26M -20.19M -42.41M -54.8M -63.35M -73.94M -65.56M -63.11M -61.94M -56.98M -53.73M